Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;50(2):102-106.
doi: 10.5152/tud.2024.23025.

Urothelial Malignancy After Normal Hematuria Clinic Investigations: Does Non-visible Hematuria Need Reinvestigation?

Affiliations

Urothelial Malignancy After Normal Hematuria Clinic Investigations: Does Non-visible Hematuria Need Reinvestigation?

Alice Thompson et al. Urol Res Pract. 2024 Mar.

Abstract

Objective: Hematuria is the most common referral to Urology. Most initial evaluations are normal; however there are few medium- to long-term studies about these patients after they are discharged.

Methods: This study was a retrospective observational case-control study. Patients with normal initial investigations in our hematuria clinic (HC) over a 2-year period in 2012-2013 were included. We reviewed the electronic records of patients choosing January 1, 2021, as our reference date providing a median follow-up of 99 months. The primary aim of this study was to assess the missed urothelial malignancy (UM) rate in this cohort and also the UM rate in those re-referred to the HC.

Results: The study included 573 patients of whom 24.6% (141/573) were re-referred to urology during the study period. The overall missed UM cancer rate was 0.5% and 0.2% died as a result in this follow-up period. The UM cancer rate in those re-referred was 4.3% and of those re-referred with visible hematuria (VH) the UM cancer rate was 5.7%. No patients re-referred with non-visible VH (NVH) were diagnosed with UM. The only urological death during this time was due to UM.

Conclusion: All urological malignancy and mortality remain very low even at mediumto long-term follow-up after an initial normal HC investigation. In this study, no patients with recurrent NVH developed UM; therefore, recurrent NVH is unlikely to need reinvestigation. The risk of UM in those re-referred with VH is low but more substantial and warrants reinvestigation, which should include computed tomography urogram imaging.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests: The authors have no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Consort diagram. HC, hematuria clinic; NVH, non-visible hematuria; UM, urothelial malignancy; VH, visible hematuria.

References

    1. Mathew A,Desai KM. An audit of urology two-week wait referrals in a large teaching hospital in England. Ann R Coll Surg Engl. 2009;91(4):310 312. (10.1308/003588409X391767) - DOI - PMC - PubMed
    1. Hawary AM,Warburton HE,Brough RJ, et al. The”2-week wait”rulefor referrals for suspected urological cancers - Urgent need for refinementof criteria. Ann R Coll Surg Engl. 2008;90(6):517 522. (10.1308/003588408X301082) - DOI - PMC - PubMed
    1. Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141(2):350 355. (10.1016/s0022-5347(17)40763-4) - DOI - PubMed
    1. Khadhouri S, Gallagher KM, MacKenzie KR, et al. The IDENTIFY Study: the Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study. BJU Int. 2021;128(4):440 450. (10.1111/bju.15483) - DOI - PubMed
    1. Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006;97(2):301 5; discussion 305. (10.1111/j.1464-410X.2006.05976.x) - DOI - PubMed

LinkOut - more resources